Skip to main content

Table 1 Patients characteristics

From: The prognostic influence of tumor infiltrating Foxp3+CD4+, CD4+ and CD8+ T cells in resected non-small cell lung cancer

Variable NSCLC Healthy subjects
n = 80 n = 16
Gender n (%):   
 Female 16 (20) 3 (18.8)
 Male 64 (80) 13 (81.2)
Age, years, median (range) 66 (45–77) 34 (19–77)**
Smoking history n (%)*   
 Non- smokers 14 (17.5) 10 (62.5)
 Smokers 66 (82.5) 6 (37.5)
Smoking pack-years, median (range) 30 (0–60) 2,5 (0–50)**
FEV1 % of pred. median (range) 83 (33–144) 93 (70–114)
FEV1/FVC ratio % of pred., median (range) 89 (49–123) 107 (86–114)
Histological NSCLC type:   
 Adenocarcinoma 38 (47.5) _
 Squamous cell carcinoma 36 (45)
 Large cell carcinoma 5 (6.2)
 Adenosquamous carcinoma 1 (1.2)
NSCLC stage:   
 Stage IA 4 (5.0) _
 Stage IB 19 (23.8)
 Stage IIA 21 (26.2)
 Stage IIB 5 (6.2)
 Stage IIIA 28 (35.0)
 Stage IIIB 3 (3.8)
T status:   
 T1a 2 (2.5) _
 T1b 11 (13.8)
 T2a 37 (46.2)
 T2b 8 (10.0)
 T3 18 (22.5)
 T4 2 (5.0)
N status   _
 N0 35 (43.8)
 N1 26 (32.5)
 N2 17 (21.2)
 N3 2 (2.5)
Diferenciation:   _
 Poor 46 (57.5)
 Other 33 (41.2)
  1. FEV 1 forced expiratory volume in one second, FVC forced vital capacity
  2. *P < 0.05, chi-square (χ 2) test
  3. **P < 0.05, Mann–Whitney U test